World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
REGNRegeneron Pharmaceuticals | $127.14bn | 28.86 | n/a |
VRTXVertex Pharmaceuticals | $125.28bn | 30.77 | n/a |
LONNLonza AG | CH₣37.91bn | 120.05 | 0.74% |
IQVIqvia Holdings | $43.52bn | 29.39 | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
ALNYAlnylam Pharmaceuticals | $34.06bn | n/a | n/a |
ARGXargenx SE | €29.18bn | n/a | n/a |
068270Celltrion | KR₩40tn | 101.69 | 0.26% |
BNTXBioNTech SE | $29.34bn | n/a | n/a |
MRNAModerna | $26.25bn | n/a | n/a |
ICLRIcon | $24.84bn | 31.88 | n/a |
SMMTSummit Therapeutics | $23.13bn | n/a | n/a |
GMABGenmab A/S | DKK114.31bn | 21.01 | n/a |
PCVXVaxcyte | $15.41bn | n/a | n/a |
UTHRUnited Therapeutics | $15.09bn | 15.55 | n/a |
ASNDAscendis Pharma A/S | $13.88bn | n/a | n/a |
INSMInsmed | $12.83bn | n/a | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
NBIXNeurocrine Biosciences | $12.34bn | 36.24 | n/a |
EXASExact Sciences | $12.11bn | n/a | n/a |